Global Health Peer Comparison

NSE: MEDANTA | BSE: 543654

₹1,357.30

₹-7.70 (-0.56%)

As on 01-Oct-2026IST

Market cap

₹36,515 Cr

Revenue (TTM)

₹4,683 Cr

P/E Ratio

65.7

P/B Ratio

8.9

Div. Yield

0 %

Edit

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Market cap (₹ Cr)	36,515	33,680	30,875	14,713	11,161
Revenue (₹ Cr)	4,683	2,891	4,213	857	1,710
Net Profit (₹ Cr)	552.34	546.30	190.80	187.49	202.82
Net Margin (%)	11.55	18.23	4.49	21.32	11.70
RoE (%)	14.93	23.03	9.45	20.58	14.13
Price to Earnings	65.65	62.15	151.12	78.47	55.36
Price-To-Book	8.88	12.89	8.16	14.61	7.16

Income Statement (₹ Cr)

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Operating Revenue	4,683.37	2,890.80	4,212.50	857.13	1,710.00
Total Income	4,783.78	2,995.90	4,248.00	879.41	1,733.17
Total Expenditure	3,704.62	2,053.10	3,379.70	495.19	1,287.72
EBITDA	978.75	837.70	832.80	361.94	422.28
Depreciation	246.41	171.60	330.60	96.06	135.28
EBIT	732.34	666.10	502.20	265.89	287.00
Interest	92.01	24.40	253.30	36.75	25.53
Other Income	100.41	105.10	35.50	22.28	23.17
Exceptional Items	-20.61	-30.10	-11.20	0.00	-8.99
Profit before Tax	720.14	716.70	273.20	251.42	275.66
Provision for Tax	167.80	170.40	82.40	63.93	72.84
Profit after Tax	552.34	546.30	190.80	187.49	202.82

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Shareholder's Funds	3,961.57	2,508.20	2,247.40	957.15	1,513.16
Minority Interest	3.84	-4.40	9.90	0.00	-1.20
Non-Current Liabilities	1,293.60	154.00	3,961.30	426.03	279.48
Current Liabilities	627.13	450.70	1,238.90	123.87	334.02
Total Liabilities	5,905.00	3,139.97	7,690.70	1,507.05	2,524.76

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Non-Current Assets	3,128.95	1,176.30	5,416.90	737.24	1,415.30
Current Assets	1,674.92	1,566.60	937.40	321.90	468.61
Total Assets	5,905.00	3,139.97	7,690.70	1,507.05	2,524.76
Total Debt*	631.08	0.00	3,244.00	0.00	18.73
Net Current Assets	1,047.79	1,115.90	-301.50	198.03	134.59
Contingent Liabilities	100.01	16.76	81.10	0.13	10.08

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Cash From Operating Activities	714.39	635.61	510.80	270.59	350.70
Cash Flow from Investing Activities	-1,089.11	-421.86	-1,451.70	-174.22	-223.13
Cash from Financing Activities	271.85	-263.57	940.30	-69.49	-115.29
Net Cash Inflow / Outflow	-102.87	-49.83	-0.60	26.88	12.28

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
ROCE (%)	19.38	29.56	11.51	30.28	20.03
ROE (%)	14.93	23.03	9.45	20.58	14.13
ROA (%)	10.35	18.64	2.83	13.49	10.13
EBIT Margin (%)	15.64	23.04	11.92	31.02	16.78
Net Margin (%)	11.55	18.23	4.49	21.32	11.70
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Revenue Growth (%)	21.27	14.29	30.90	20.18	21.80
EBIT Growth (%)	0.94	15.64	-16.88	26.22	43.53
Net Profit Growth (%)	3.43	5.38	-52.81	24.27	32.87
EPS Growth (%)	2.70	-30.51	-42.60	23.44	-16.64
Book Value Growth (%)	16.51	15.41	5.13	21.86	13.54

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Price / Earnings	63.76	47.07	139.13	78.33	21.86
Price / Book Value	8.88	12.89	8.16	14.61	7.16
Dividend Yield (%)	0.04	1.02	0.00	0.14	0.93
EV/EBITDA	36.80	38.61	40.86	39.87	25.99
Market Cap (₹ Cr)	25,841.07	22,015.15	24,901.98	8,864.05	8,992.90

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Debt to Equity	0.15	0.00	1.19	0.00	0.00
Short term debt to equity ratio	--	--	0.15	--	0.01
Current Ratio	2.67	3.48	0.76	2.60	1.40
Quick Ratio	2.54	3.38	0.68	2.56	1.27
Interest Coverage	8.83	30.37	2.08	7.84	11.80

	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno	Metropolis Health
Debtors to sales (%)	8.78	3.83	13.16	2.43	9.96
Asset Turnover	0.88	0.99	0.62	0.62	0.85
Receivable days	29.09	13.13	44.38	7.98	35.29
Inventory Days	6.05	5.28	7.52	2.20	10.35
Payable days	80.04	118.67	133.54	136.27	143.56
Cash Conversion Cycle	-44.90	-100.26	-81.64	-126.08	-97.92

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.